摘要：

Transdermal system comprises: at least one aromatase inhibitor as an active substance, preferably at least one active substance from non-steroidal and steroidal aromatase inhibitors and group formed from their derivatives; an active substance puller protection layer; an active substance reservoir; an optionally active substance permeable membrane; and a carrier for an active substance reservoir or an optional membrane.

展开